Search

everythinglearnresearchcommunity

for

Search:↓

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Increasing Smurf2 hinders hair follicle stem cell differentiation and wound healing.

Smeathxanthone A improves wound healing and lowers blood sugar in diabetic mice.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Marine compounds from gorgonians and soft corals show promise for drug development, especially for chronic disorders.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Targeting the MC-5-HT-HTR2A axis may help treat chronic itching.

Chloroquine and cinchonine relax rat blood vessels by affecting calcium channels, with chloroquine needing caution in heart patients.

Clascoterone may be an effective topical treatment for hair loss.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Lower SMAD2/3 activation predicts more severe skin cancer.

The new delivery system improves Alzheimer's symptoms by releasing Huperzine A slowly and effectively.

The combined treatment of Finasteride and Doxazosin affects prostate tissue by reducing cell growth and altering hormone levels.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

α-Mangostin can naturally lighten skin by reducing melanin.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

MEK and BRAF inhibitors increase sebum production and accumulation, which could cause acne-like side effects.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Compound 4 is a promising treatment for hair loss with low toxicity.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Finasteride may help improve certain brain function issues linked to dopamine.